BL
BLOZF.US Cannabix Technologies Inc
- Market cap
- USD 31.5M
- P/E
- -
- P/B
- 34.52x
- ROE
- -155.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.
Is BLOZF.US undervalued?
Graham numberThe Graham number of Cannabix Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cannabix Technologies Inc fundamental analysis
No fundamental analysis for Cannabix Technologies Inc yet.
Cannabix Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cannabix Technologies Inc
Cannabix Technologies Inc. develops marijuana and alcohol breathalyzer technologies for law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) system for tetrahydrocannabinol (THC) detection and quantification, which includes the Cannabix Breath Collection Unit (BCU) and Breath Cartridge (BC) for non-invasive, portable, standardized human breath sample collection, storage, and transportation. The company also provid…
Full company profileCannabix Technologies Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cannabix Technologies Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 6.57M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -2.56K | -17.1K | -20.3K | -21.4K | -25.6K | -29.2K | -126K | -153K | -122K | -173K | -177K |
| Operating Income | -3.53M | -1.34M | -3.83M | -3.18M | -9.11M | -3.11M | -2.01M | -2.96M | -4.42M | -6.00M | -2.15M |
| EBITDA | -3.53M | -1.34M | -3.83M | -6.89M | -9.11M | -3.11M | -2.01M | -2.96M | -3.22M | -6.01M | -1.97M |
| Net Income | -3.73M | -1.47M | -3.88M | -6.97M | -9.24M | -3.37M | -2.14M | -3.13M | -4.69M | -5.76M | -2.13M |
| EPS | -0.05 | -0.02 | -0.04 | -0.07 | -0.09 | -0.03 | -0.02 | -0.03 | -0.04 | -0.05 | -0.02 |
| Balance Sheet | |||||||||||
| Total Assets | 7.60M | 15.1M | 14.6M | 8.74M | 10.4M | 8.76M | 6.95M | 4.70M | 3.00M | 2.21M | 1.71M |
| Total Liabilities | 158K | 187K | 213K | 92.2K | 80.8K | 121K | 237K | 248K | 448K | 432K | 350K |
| Shareholders' Equity | 7.44M | 14.9M | 14.3M | 8.64M | 10.3M | 8.64M | 6.71M | 4.45M | 2.55M | 1.78M | 1.36M |
| Cash & Short-term Investments | 3.55M | 11.0M | 10.3M | 8.44M | 10.1M | 8.45M | 6.52M | 4.26M | 2.35M | 1.59M | 1.13M |
| Total Debt | - | - | - | - | - | 133K | 133K | 155K | 159K | 160K | 125K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.15M | -1.38M | -1.83M | -1.89M | -1.71M | -2.13M | -1.97M | -2.08M | -1.84M | -1.73M | -1.68M |
| Capital Expenditure | 52.0K | 119K | 56.4K | 75.8K | 75.8K | 4.59K | 28.6K | 29.1K | 24.4K | 4.08 | 17.00 |
| Free Cash Flow | -1.20M | -1.50M | -1.88M | -1.89M | -1.79M | -2.13M | -2.00M | -2.11M | -1.86M | -1.73M | -1.68M |
| Ratios | |||||||||||
| ROE | -50.2% | -9.8% | -27.1% | -80.6% | -89.7% | -39.0% | -31.9% | -70.2% | -183.7% | -323.4% | -155.9% |
| ROA | -49.1% | -9.7% | -26.7% | -79.8% | -89.0% | -38.4% | -30.8% | -66.5% | -156.3% | -260.3% | -124.1% |
| Net Profit Margin | - | - | - | - | -140.6% | - | - | - | - | - | - |
| Debt to Equity | - | - | - | - | - | 0.02x | 0.02x | 0.03x | 0.06x | 0.09x | 0.09x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cannabix Technologies Inc dividends
Cannabix Technologies Inc has not paid dividends in the last 9 fiscal years.
Who owns Cannabix Technologies Inc
- Insiders 11.69%
- Institutions 0.02%
- Public & others 88.30%
- Shares outstanding 123M
- Free float 115M
Cannabix Technologies Inc company profile
- Company name
- Cannabix Technologies Inc
- Ticker
- BLOZF.US
- ISIN
- CA13765L1013
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- April
- Address
- 501 - 3292 Production Way, Burnaby, BC, Canada, V5A 4R4
- Phone
- 604 551 7831
- Website
- cannabixtechnologies.com
About Cannabix Technologies Inc
Cannabix Technologies Inc. develops marijuana and alcohol breathalyzer technologies for law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) system for tetrahydrocannabinol (THC) detection and quantification, which includes the Cannabix Breath Collection Unit (BCU) and Breath Cartridge (BC) for non-invasive, portable, standardized human breath sample collection, storage, and transportation. The company also provides BreathLogix, an autonomous alcohol screening system for rapid and repeatable high-volume screening in various employment settings. In addition, the company develops other TCH-detecting technologies, including mass spectrometer breath sampler (MSBS) technology, as well as high-field asymmetric waveform ion mobility spectrometry (FAIMS) and FAIMS-mass spectrometer systems. It has a strategic partnership and development agreement with Omega Laboratories Inc. for the development and commercialization of MBT technology. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
Cannabix Technologies Inc management
3- Mr. Ravinder S. Mlait B.A., M.B.A.CEO & Director · born 1976
- Mr. Bryan E. Loree B.A., C.M.A., C.P.A.CFO, Corporate Secretary & Director · born 1976
- Dr. Moe Paknahad Ph.D.Vice President of Technology Development